Title: Matthias Bräutigam: Innovator in Pharmaceutical Preparations
Introduction
Matthias Bräutigam is an inventor based in Berlin, Germany. He is currently associated with Berlirem GmbH. Although he has not yet been granted any patents, his work focuses on innovative solutions for treating neurodegenerative diseases.
Latest Patent Applications
Bräutigam's latest patent applications include a novel kit of pharmaceutical preparations for the treatment of neurodegenerative diseases. This invention specifically addresses the needs of Parkinson's patients who require Continuous Dopaminergic Stimulation. The kit comprises levodopa and an AADC-inhibitor, which is crucial for effective treatment. The application details how levodopa can be administered via continuous subcutaneous infusion or through an oral modified release formulation. The invention also emphasizes the importance of using an oral COMT-inhibitor to prevent levodopa conjugation, thereby enhancing the treatment's efficacy. Another application involves the use of high doses of monomeric contrast medium containing iodine in X-ray diagnostics, particularly for patients with restricted kidney function.
Conclusion
Matthias Bräutigam is making significant strides in the field of pharmaceutical innovations, particularly in the treatment of neurodegenerative diseases. His contributions have the potential to improve the quality of life for many patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.